Acura Pharmaceuticals

Acura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse.[2] As of 2012, the company had several opioid products under development, which would use "Aversion Technology".[3] As of 2014, it was a publicly traded company, listed on NASDAQ under the symbol "ACUR".

Acura Pharmaceuticals Inc.
TypePublic
Nasdaq: ACUR
IndustryPharmaceutical industry
Founded1935[general 1]: 3 
HeadquartersPalatine, Illinois
ProductsPharmaceuticals
Revenue US$ .75 million (2015)[1]
Websiteacurapharm.com

History

In 2013, the Company settled Oxecta patent litigation with Impax Laboratories (IPXL) and Par Pharmaceutical.[4]

License agreements

The company has an agreement to license, develop and commercialize opioid analgesic products with King Pharmaceuticals.[5]

Product adoptions

In 2013, multiple retailers – including Kroger and Fruth Pharmacy – stocked Acura's product Nexafed.[6][7]

References
  1. "Acura Pharmaceuticals Financial Statements". United States Securities and Exchange Commission.
  2. "Acura Pharmaceuticals Announces Second Quarter 2020 Financial Results". AP NEWS. 2020-08-14. Retrieved 2021-07-22.
  3. "Acura Pharmaceuticals, Inc". Google Finance. 266634. Retrieved February 15, 2014.
  4. "Acura Pharmaceuticals Inc Announces Settlement of Oxecta Patent Litigation With Par Pharmaceutical and Impax Laboratories Inc". Reuters. Reuters. October 9, 2013. Archived from the original on February 15, 2014.
  5. "ACURA PHARMACEUTICALS INC (ACUR) Company Profile & Facts - Yahoo Finance".
  6. Olsavsky, Rebecca (February 4, 2014). "Kroger stocks meth-resistant drug". Herald-Star. Archived from the original on February 15, 2014. Retrieved February 15, 2014.
  7. "New Pseudoephedrine Drug Could Hop Back Over the Counter". PharmExec. Retrieved 2021-07-22.

General references
  1. "ACURA PHARMACEUTICALS, INC" (PDF). EDGAR Online. Form 10-K, 1996. Acura Pharmaceuticals. March 31, 1997. Retrieved February 15, 2014.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.